2025 Scrip Asia 100
Latest Updates And Considerations In Asia Pacific
Digital Innovation
Technological advances, such as generative AI and digital therapeutics, have become promising tools for drug developers, helping APAC organizations compete in a rapidly evolving global landscape.
Korea Looks To Close Gap In AI Drug Development Capabilities
Syntekabio CSO HeaKyoung Cho talks to Scrip how the AI-driven drug development situation in Korea compares with global trends and what the domestic industry needs to do to survive rising competition at home and abroad.
GenAI Reality In Pharma Amid Hype, Advances In LLMs For Therapeutics
Indegene’s CTO talks to Scrip about the state of GenAI implementations in pharma amid hype and limited clarity on ROI, the need to address foundational issues early on, promising pilots, the firm’s alliance with Microsoft and Google’s generalist LLM for therapeutics.
